Cargando…
Screening of mutations in NOL3 in a myoclonic syndromes series
Autores principales: | Macerollo, A., Mencacci, N. E., Erro, R., Cordivari, C., Edwards, M. J., Wood, N. W., Bhatia, Kailash P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155162/ https://www.ncbi.nlm.nih.gov/pubmed/25138476 http://dx.doi.org/10.1007/s00415-014-7463-z |
Ejemplares similares
-
Reply: Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers
por: Mencacci, Niccolo E., et al.
Publicado: (2015) -
Progressive Myoclonic Epilepsy Due to Lafora Body Disease with a Novel Mutation
por: Israni, Anil V., et al.
Publicado: (2018) -
NOL7 facilitates melanoma progression and metastasis
por: Li, Yumei, et al.
Publicado: (2021) -
The Emerging Role of Phosphodiesterases in Movement Disorders
por: Erro, Roberto, et al.
Publicado: (2021) -
Clinical Evaluation of 38 Patients with Juvenile Myoclonic Epilepsy
por: NASER MOGHADASI, Abdorreza, et al.
Publicado: (2014)